Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Archives of General Surgery(Electronic Edition) ›› 2020, Vol. 14 ›› Issue (05): 326-330. doi: 10.3877/cma.j.issn.1674-0793.2020.05.002

Special Issue:

• Original Article • Previous Articles     Next Articles

FOXC2 affects the invasion and migration ability of breast cancer by Hedgehog/Gli signaling pathway

Hongbo Qu1,(), Dixian Luo2, Lili Duan2, Xiongqiang Hu1, Chengyi Wu3   

  1. 1. Department of Breast and Thyroid Surgery, the First People’s Hospital of Chenzhou, Chenzhou 423000, China
    2. Translational Medicine Institute, the First People’s Hospital of Chenzhou, Chenzhou 423000, China
    3. Department of Endocrine Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
  • Received:2020-03-07 Online:2020-10-01 Published:2020-10-01
  • Contact: Hongbo Qu
  • About author:
    Corresponding author: Qu Hongbo, Email:

Abstract:

Objective

To explore the mechanism of FOXC2 mediated Hedgehog/Gli signaling pathway involved in breast cancer invasion and migration by regulating epithelium mesenchymal transformation (EMT).

Methods

Breast cancer MDA-MB-231 cells were treated with different concentrations Cyclopamine-a Hedgehog/Gli signaling pathway inhibitor. MTT method was used to detect the cell proliferation inhibition rate and calculated the drug half inhibitory concentration (IC50). Cyclopamine or silencing FOXC2 expression by RNA interference (siRNA) was used to block the Hedgehog/Gli signaling pathway activation. Transwell chamber invasion assay and scratch assay were used to detect invasion and migration ability of MDA-MB-231 cells after blocking Hedgehog/Gli signal pathway respectively. Western blotting was used to detect the expression of Hedgehog/Gli signaling pathway molecules Smoothened (Smo), Gli1 and EMT-related markers E-cadherin and Vimentin protein before and after blocking Hedgehog/Gli signaling pathway.

Results

Compared with the blank control group, Cyclopamine could significantly inhibit the MDA-MB-231 cells proliferation and showed a time-dose effect relationship. The half inhibition inhibitory concentration was 25 μmol/L after 48 hour. Transwell chamber invasion assay and wound healing assay showed that FOXC2-siRNA group and Cyclopamine group penetrating cells and migration rates were significantly lower, as compared with the untransfected group and Control-siRNA group. The difference was statistically significant (P<0.05). Western blotting results also showed that the expression of Smo, Gli1 and FOXC2 protein was significantly decreased in FOXC2-siRNA group and Cyclopamine group, as compared with the untransfected group and Control-siRNA group (P<0.05). The expression of Vimentin protein was significantly decreased and the expression of E-cadherin protein was increased when silencing FOXC2 expression, the differences were statistically significant (P<0.05).

Conclusions

FOXC2 mediates Hedgehog/Gli signaling pathway involved in breast cancer invasion and migration by regulating EMT. It is suggested that blocking the Hedgehog/Gli signal pathway may be a new targeted therapy of breast cancer.

Key words: FOXC2, Hedgehog/Gli signal pathway, Epithelial-mesenchymal transition, Breast tumor, Invasion and metastasis

京ICP 备07035254号-20
Copyright © Chinese Archives of General Surgery(Electronic Edition), All Rights Reserved.
Tel: 020-87331056 E-mail: pwwxcma2007@126.com
Powered by Beijing Magtech Co. Ltd